Latest Breaking News On - Samatha yohn - Page 1 : comparemela.com

Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short- and long-term clinical trials.

United statesRaymond ortonRonald marcusInvega trinzaSamatha yohnBristol myers squibbCenexel hassman research instituteSchizophrenia international research societyKaruna therapeuticsPsychiatric timesNew drug applicationBristol myersAnnual congressSchizophrenia international research